Mitchell McLeod Pugh & Williams’s Merck MRK Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81M	Buy	23,390 +744	+3%	+$85.9K	0.42%	48
2025 Q4	$2.76M	Sell	22,646 -138	-0.6%	-$13K	0.39%	51
2025 Q3	$1.98M	Sell	22,784 -964	-4%	-$79.4K	0.32%	63
2025 Q2	$1.88M	Buy	23,748 +530	+2%	+$42.1K	0.35%	63
2025 Q1	$2.08M	Sell	23,218 -201	-0.9%	-$18.8K	0.43%	49
2024 Q4	$2.33M	Buy	23,419 +178	+0.8%	+$18.4K	0.49%	43
2024 Q3	$2.64M	Buy	23,241 +362	+2%	+$43K	0.55%	39
2024 Q2	$2.83M	Buy	22,879 +174	+0.8%	+$22.4K	0.65%	34
2024 Q1	$3M	Sell	22,705 -209	-0.9%	-$25.8K	0.72%	29
2023 Q4	$2.5M	Sell	22,914 -222	-1%	-$23K	0.66%	34
2023 Q3	$2.38M	Buy	23,136 +629	+3%	+$67.8K	0.7%	32
2023 Q2	$2.6M	Sell	22,507 -113	-0.5%	-$12.8K	0.75%	29
2023 Q1	$2.41M	Buy	22,620 +124	+0.6%	+$13.4K	0.75%	28
2022 Q4	$2.5M	Buy	22,496 +651	+3%	+$66.5K	0.84%	26
2022 Q3	$1.88M	Buy	21,845 +2,378	+12%	+$212K	0.72%	29
2022 Q2	$1.77M	Buy	19,467 +167	+0.9%	+$14.8K	0.69%	32
2022 Q1	$1.58M	Buy	19,300 +313	+2%	+$24.7K	0.53%	55
2021 Q4	$1.46M	Buy	18,987 +835	+5%	+$66.5K	0.48%	57
2021 Q3	$1.36M	Buy	18,152 +130	+0.7%	+$9.89K	0.51%	56
2021 Q2	$1.4M	Buy	18,022 +92	+0.5%	+$6.84K	0.54%	52
2021 Q1	$1.32M	Buy	17,930 +412	+2%	+$30.4K	0.55%	50
2020 Q4	$1.37M	Sell	17,518 -23	-0.1%	-$1.76K	0.63%	44
2020 Q3	$1.39M	Buy	17,541 +747	+4%	+$58.5K	0.71%	35
2020 Q2	$1.24M	Buy	16,794 +3,280	+24%	+$247K	0.7%	41
2020 Q1	$992K	Buy	13,514 +1,419	+12%	+$112K	0.77%	40
2019 Q4	$1.05M	Sell	12,095 -478	-4%	-$39.3K	0.66%	45
2019 Q3	$1.01M	Sell	12,573 -234	-2%	-$18.8K	0.68%	43
2019 Q2	$1.02M	Sell	12,807 -235	-2%	-$18K	0.7%	41
2019 Q1	$1.03M	Buy	13,042 +466	+4%	+$34.9K	0.72%	41
2018 Q4	$917K	Sell	12,576 -73	-0.6%	-$5.15K	0.74%	44
2018 Q3	$856K	Buy	12,649 +590	+5%	+$37.6K	0.58%	54
2018 Q2	$698K	Sell	12,059 -189	-2%	-$10.7K	0.49%	71
2018 Q1	$637K	Buy	12,248 +315	+3%	+$17K	0.46%	79
2017 Q4	$641K	Sell	11,933 -1,520	-11%	-$84.3K	0.44%	84
2017 Q3	$822K	Sell	13,453 -786	-6%	-$47.7K	0.61%	58
2017 Q2	$871K	Sell	14,239 -352	-2%	-$21.4K	0.66%	54
2017 Q1	$885K	Sell	14,591 -844	-5%	-$51.2K	0.69%	47
2016 Q4	$867K	Buy	15,435 +1,530	+11%	+$89.5K	0.7%	48
2016 Q3	$828K	Sell	13,905 -719	-5%	-$42K	0.73%	48
2016 Q2	$804K	Buy	14,624 +1,562	+12%	+$83.1K	0.73%	51
2016 Q1	$659K	Buy	13,062 +331	+3%	+$16.2K	0.64%	58
2015 Q4	$642K	Buy	12,731 +649	+5%	+$32.7K	0.64%	56
2015 Q3	$569K	Buy	12,082 +398	+3%	+$21.1K	0.59%	61
2015 Q2	$635K	Sell	11,684 -126	-1%	-$7.07K	0.58%	62
2015 Q1	$648K	Sell	11,810 -121	-1%	-$6.85K	0.59%	63
2014 Q4	$647K	Buy	+11,931	New	+$665K	0.6%	61

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mitchell McLeod Pugh & Williams's MRK Position: Q1 2026 in Review

Mitchell McLeod Pugh & Williams increased its Merck (MRK) stake by 3.3% in Q1 2026, buying an estimated $85.9K and bringing the position to 23,390 shares worth $2.81M. The position accounts for 0.42% of the portfolio, ranked #48.

Mitchell McLeod Pugh & Williams first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $3M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Mitchell McLeod Pugh & Williams held 23,390 shares of Merck worth $2.81M as of Q1 2026.
Mitchell McLeod Pugh & Williams bought 744 Merck shares in Q1 2026, an estimated $85.9K.
Merck made up 0.42% of Mitchell McLeod Pugh & Williams's portfolio in Q1 2026, its #48 holding.
Mitchell McLeod Pugh & Williams first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
Mitchell McLeod Pugh & Williams's Merck position peaked at $3M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q1 2026, filed 24 Apr 2026.